0
0

To amend title XI of the Social Security Act to adjust which engineered cyclic peptides are qualifying single source drugs for purposes of the Drug Price Negotiation Program.

5/16/2026, 8:07 AM

Summary of Bill HR 8857

The bill titled "To amend title XI of the Social Security Act to adjust which engineered cyclic peptides are qualifying single source drugs for purposes of the Drug Price Negotiation Program," was introduced in the 119th Congress on May 15, 2026.

Current Status of Bill HR 8857

Bill HR 8857 is currently in the status of Bill Introduced since May 15, 2026. Bill HR 8857 was introduced during Congress 119 and was introduced to the House on May 15, 2026.  Bill HR 8857's most recent activity was Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of May 15, 2026

Bipartisan Support of Bill HR 8857

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
3
Democrat Cosponsors
1
Republican Cosponsors
2
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 8857

Primary Policy Focus

Alternate Title(s) of Bill HR 8857

To amend title XI of the Social Security Act to adjust which engineered cyclic peptides are qualifying single source drugs for purposes of the Drug Price Negotiation Program.
To amend title XI of the Social Security Act to adjust which engineered cyclic peptides are qualifying single source drugs for purposes of the Drug Price Negotiation Program.

Comments